Healthcare -
Biotechnology - NASDAQ - US
$ 20.815
-2.73 %
$ 1.85 B
Market Cap
-5.11
P/E
TVTX - GROSS PROFIT
Gross Profit TVTX - Travere Therapeutics, Inc.
233 M
LAST VALUE
6.80%
2 YEAR CAGR
6.51%
5 YEAR CAGR
23.77%
10 YEAR CAGR